Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
(5 ) : , 5 vials * 5 mg : +2+8 C
The SURMOUNT-2 trial in patients with both obesity and type 2 diabetes showed somewhat lower but still impressive results: 12.8% to 14.7% weight loss over 72 weeks
It is most often studied in combination with semaglutide (a GLP-1 receptor agonist) in a fixed-dose combination known as CagriSema, investigated in the REDEFINE trial programme
Other copper-peptide complexes exist in research literature, but GHK-Cu is the one most closely associated with the term because it was the first to be isolated and remains the most widely referenced in copper-peptide research
US$ 27.66
US$ 24.05
US$ 27.88
